Pioglitazone to Reduce Sympathetic Overactivity in CKD Patients

Recruiting

PioglitazonePioglitazone to Reduce Sympathetic Overactivity in CKD Patients

Sponsor:

The University of Texas at Arlington

Code:

NCT03471117

Conditions

Chronic Kidney Diseases

Eligibility Criteria

Sex: All

Age: 35 - 70

Healthy Volunteers: Not accepted

Interventions

Pioglitazone

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-08-16. This information was provided to ClinicalTrials.gov by The University of Texas at Arlington on 2024-05-23.